DATE9 Jul
NIFTY 23,963 0.34%BANK NIFTY 57,252 0.90%NIFTY IT 27,471 0.30%NIFTY PHARMA 25,656 0.89%KALYANKJIL 443 18.40%MAPMYINDIA 1,069 14.79%CHOICEIN 830 7.98%SWIGGY 281 7.47%LODHA 1,192 6.91%KAYNES 3,429 6.80%CGCL 253 6.57%KIRLOSENG 2,425 6.49%SAREGAMA 476 6.46%BRIGADE 534 6.22%NIFTY 23,963 0.34%BANK NIFTY 57,252 0.90%NIFTY IT 27,471 0.30%NIFTY PHARMA 25,656 0.89%KALYANKJIL 443 18.40%MAPMYINDIA 1,069 14.79%CHOICEIN 830 7.98%SWIGGY 281 7.47%LODHA 1,192 6.91%KAYNES 3,429 6.80%CGCL 253 6.57%KIRLOSENG 2,425 6.49%SAREGAMA 476 6.46%BRIGADE 534 6.22%
Morning brief · Friday, 10 July 2026

LIC takes new Rs 700 crore bite of Natco Pharma

Market pulse
Indian markets ended the week on a positive note, with banking and pharmaceutical stocks driving the benchmark Nifty 50 to a fresh high just shy of 24,000, even as the information technology sector saw some profit booking. Amidst the broader market strength, specific counters like Kalyan Jewellers and Mapmyindia stole the show, posting spectacular double digit gains.
From the investor's mind
One post worth your time, explained
Deepak Shenoy
@deepakshenoy · on X
The upcoming earnings season is expected to show a mixed performance across sectors, according to Deepak Shenoy. Early indications suggest that banks are likely to report strong results, while the retail sector is not anticipated to perform as well. Shenoy notes that expectations for the IT sector are low. He also highlighted that much of the auto sector appears to have experienced a favorable period, and he intends to scrutinize the reported "losses" from Oil Marketing Companies this quarter.
Word in the street
What the wider market is buzzing about
Wendt (India) Limited
7,665Past year 21%M.cap ₹1,542 Cr
A nearly 21 percent slide over the last year in the shares of Wendt (India) Limited has not gone unnoticed. The roughly 1,542 crore company finds itself at the center of a debate. Some see a company with a strong moat, citing its new products like Carbide Plates and LPDMS, which are used in semiconductor manufacturing, as a positive sign. Others are focused on the numbers, questioning why sales growth has stalled and operating margins have declined since the exit of 3M. The question being asked is whether 3M was a high-margin customer who has since been replaced by less profitable ones.
Know more about the stock
Yesterday's big moves
Natco Pharma Limited
Natco Pharma LimitedNew Position
966Past year 5%M.cap ₹17,221 Cr
LIC
LIC initiated a new position in Natco Pharma, acquiring 40,09,317 shares, representing a 2.24% stake. The investment is valued at ₹385.54 Cr based on Natco Pharma's share price of ₹961.60.
Aavas Financiers Limited
Aavas Financiers LimitedNew Position
1,500Past year 24%M.cap ₹11,938 Cr
Massachusetts Institute Of Technology
Massachusetts Institute Of Technology initiated a new position in Aavas Financiers with 8,70,411 shares, representing a 1.10% stake, valued at ₹131.06 crore based on the share price of ₹1505.30.
Vishal Mega Mart Limited
Vishal Mega Mart LimitedNew Position
116Past year 12%M.cap ₹54,666 Cr
Axis Mutual Fund
Axis Mutual Fund took a new position in Vishal Mega Mart Limited, acquiring 8,94,31,616 shares, equivalent to a 1.91% stake, valued at ₹1043.68 crore at a share price of ₹116.69.
Maharashtra Seamless Limited
Maharashtra Seamless LimitedIncreased
583Past year 16%M.cap ₹7,919 Cr
odd & Even Trades & finance Ltd
Odd & Even Trades & Finance Ltd. raised its stake in Maharashtra Seamless from 18.16% to 19.44%, buying 17,17,618 shares in an open market transaction.
PC Jeweller Limited
PC Jeweller LimitedNew Position
10Past year 47%M.cap ₹8,415 Cr
UNICO Global Opportunities Fund Limited
Unico Global Opportunities acquired 5.45 Cr shares of PC Jeweller, a 5.76% stake, via a warrants issue.
Only buy something that you would be perfectly happy to hold if the market shut down for ten years.
Warren Buffett
See what the smart money is buying, before the news does
Follow Kacholia, Damani, Rekha Jhunjhunwala and 300+ top investors. Every new position, bulk deal and insider trade, the moment it happens.
LIC takes new Rs 700 crore bite of Natco Pharma · WhaleWatch